galantamine and Cholera Infantum

galantamine has been researched along with Cholera Infantum in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (25.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoeffle-Maas, A; Jordis, U; Koepke, AK; Ludwig, J; Maelicke, A; Maus, A; Samochocki, M	1
DIANKOV, L; LESEV, M	1
Herrmann, N; Lanctôt, KL; Thompson, S	1
McCain, KR; Sawyer, TS; Spiller, HA	1

Reviews

1 review(s) available for galantamine and Cholera Infantum

Article	Year
The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease. Expert opinion on drug safety, 2004, Volume: 3, Issue:5 Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome	2004

Article

Year

The benefits and risks associated with cholinesterase inhibitor therapy in Alzheimer's disease.

Expert opinion on drug safety, 2004, Volume: 3, Issue:5

Topics: Aged; Alzheimer Disease; Animals; Basal Ganglia Diseases; Bradycardia; Central Nervous System Diseases; Cholinesterase Inhibitors; Clinical Trials as Topic; Comorbidity; Donepezil; Double-Blind Method; Drug Evaluation; Drug Interactions; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Institutionalization; Longitudinal Studies; Male; Memantine; Meta-Analysis as Topic; Mice; Middle Aged; Nootropic Agents; Phenylcarbamates; Piperidines; Randomized Controlled Trials as Topic; Rivastigmine; Single-Blind Method; Sleep Wake Disorders; Treatment Outcome

2004

Other Studies

3 other study(ies) available for galantamine and Cholera Infantum

Article	Year
Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy. Journal of molecular neuroscience : MN, 2010, Volume: 40, Issue:1-2 Topics: Acetylcholine; Alzheimer Disease; Animals; Brain; Brain Chemistry; Cholinesterase Inhibitors; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ferrets; Galantamine; Gastrointestinal Diseases; Humans; Mice; Scopolamine; Synaptic Transmission; Treatment Outcome	2010
[USE OF NIVALINE IN FUNCTIONAL ROENTGENDIAGNOSIS OF GASTRIC DISEASES]. Klinicheskaia meditsina, 1964, Volume: 42 Topics: Biomedical Research; Galantamine; Gastrointestinal Diseases; Neoplasms; Pharmacology; Radiography; Stomach Diseases	1964
Evaluation of centrally acting cholinesterase inhibitor exposures in adults. The Annals of pharmacotherapy, 2007, Volume: 41, Issue:10 Topics: Adult; Aged; Aged, 80 and over; Cholinesterase Inhibitors; Donepezil; Female; Galantamine; Gastrointestinal Diseases; Humans; Indans; Male; Middle Aged; Phenylcarbamates; Piperidines; Poison Control Centers; Retrospective Studies; Rivastigmine; Tacrine	2007